Accretion Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
69.14 Cr.
|
P/BV
|
4.18
|
Book Value (Rs.)
|
14.87
|
52 Week High/Low (Rs.)
|
83/60
|
FV/ML
|
10/1200
|
P/E(X)
|
10.18
|
Bookclosure
|
|
EPS (Rs.)
|
6.11
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | |
PER SHARE RATIOS | | | | |
| | | | |
Basic EPS (Rs.) | 8.48 | 9.69 | 0.27 | 0.25 |
Diluted EPS (Rs.) | 8.48 | 9.69 | 0.27 | 0.25 |
Cash EPS (Rs.) | 9.26 | 11.81 | 2.67 | 2.89 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 18.71 | 13.37 | 10.00 | 10.00 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 18.71 | 13.37 | 10.00 | 10.00 |
Revenue From Operations / Share (Rs.) | 70.23 | 84.16 | 76.47 | 72.46 |
PBDIT / Share (Rs.) | 14.66 | 19.41 | 5.57 | 6.28 |
PBIT / Share (Rs.) | 13.71 | 17.29 | 3.16 | 3.64 |
PBT / Share (Rs.) | 11.95 | 14.40 | 0.36 | 0.33 |
Net Profit / Share (Rs.) | 8.31 | 9.69 | 0.27 | 0.25 |
| | | | |
PROFITABILITY RATIOS | | | | |
| | | | |
PBDIT Margin (%) | 20.87 | 23.05 | 7.27 | 8.66 |
PBIT Margin (%) | 19.52 | 20.54 | 4.13 | 5.02 |
PBT Margin (%) | 17.01 | 17.11 | 0.47 | 0.46 |
Net Profit Margin (%) | 11.84 | 11.51 | 0.35 | 0.35 |
Return on Networth / Equity (%) | 44.44 | 72.46 | 2.70 | 2.56 |
Return on Capital Employeed (%) | 67.27 | 55.84 | 17.99 | 18.64 |
Return On Assets (%) | 17.03 | 14.32 | 0.50 | 0.44 |
Long Term Debt / Equity (X) | 0.07 | 1.29 | 0.74 | 0.94 |
Total Debt / Equity (X) | 0.92 | 2.52 | 2.20 | 2.47 |
Asset Turnover Ratio (%) | 1.71 | 1.41 | 1.53 | 0.00 |
| | | | |
LIQUIDITY RATIOS | | | | |
| | | | |
Current Ratio (X) | 1.44 | 1.47 | 1.05 | 1.01 |
Quick Ratio (X) | 0.55 | 0.48 | 0.48 | 0.42 |
Inventory Turnover Ratio (X) | 2.49 | 2.25 | 3.22 | 0.00 |
| | | | |
COVERAGE RATIOS | | | | |
| | | | |
Interest Coverage Ratio (%) | 8.33 | 6.73 | 1.99 | 1.90 |
Interest Coverage Ratio (Post Tax) (%) | 5.73 | 4.36 | 1.10 | 1.08 |